Scrip    Clinica    RAJ    Scrip Clinical Research    AnimalPharm
Email ID
Password
Forgotten your password?
Home
Therapy Sector
Generics
Business
Policy & Regulation
Research & Development
International
Product Approvals
|
Clinical Trials
|
Product Filings
|
Product Safety
|
Preclinical
|
Product Delays
|
Research & Development - Product Filings
EVENTS
17 March 2010
Berlin, Germany
17 March 2010
Berlin, Germany
22 March 2010
London, UK
JOB OF THE WEEK Promote your vacancy here
DIRECTORY Scrip Directory 2009
FDA panel backs InterMune's pulmonary fibrosis drug Esbriet despite reservations
10 March 2010
By a decisive 9-3 vote, the US FDA 's advisory committee on pulmonary drugs on March 9th recommended that the agency approve the new drug application (NDA) from InterMune to market as a treatment its drug Esbriet (pirfenidone) to reduce the decline ...
FDA criminal division may increase misdemeanour prosecutions against execs
10 March 2010
The US FDA may in the future look to increase prosecution of "responsible corporate officials" in both the pharmaceutical and food industry, Commissioner Margaret Hamburg has stated in a letter, which followed a scathing new government report ...
FDA panel to review NicOx's anti-inflammatory naproxcinod
08 March 2010
A joint meeting of the US FDA's arthritis drugs advisory committee and the drug safety and risk management advisory committee has been scheduled for May 12th to review NicOx's anti-inflammatory agent naproxcinod for the treatment of osteoarthritis. ...
Japanese recommendation moves alogliptin closer to the market
04 March 2010
An advisory committee to Japan's ministry of health, labour and welfare has recommended for approval Takeda 's oral antidiabetic, alogliptin. The positive opinion moves the DPP-4 inhibitor closer to what is likely to be its first market, following ...
US FDA issues two new clinical trial design guidances
04 March 2010
The US FDA has issued two new draft guidance documents regarding clinical trial designs: Guidance for Industry: Adaptive Design Clinical Trials for Drugs and Biologics, and Guidance for Industry: Non-inferiority Clinical Trials. The guidances, ...
 
Market Insight - Pharma sector in Turkey to shrink 25% under tough conditions
02 March 2010
The pharmaceutical industry has long eyed Turkey as one of its key emerging markets, but recent government action, which could see medicine access delayed by years, is giving it a wake-up call, ...
Market Insight - Fear gives way to prudence as VCs eye return of bull biotech market
19 February 2010
2009 was a bad year for investment in the biotech sector, with venture capital funds fleeing to safer havens and many small firms struggling to get enough financing to keep their R&D projects afloat. ...
Market Insight - Microdosing reaching a tipping point?
05 February 2010
Advocates of microdosing, a technique that involves testing very small doses of products in humans, think it will improve the efficiency of drug development by flagging at an early stage those ...
 
Light Sciences Oncology - making light-activated drug therapy a commercial reality
12 March 2009
As Dr Keltner pulled out what looked like a computer mouse from his briefcase, I was surprised to hear him say it was in fact Litx, the company's innovative light-activated drug technology. It didn't ...
Japan's biosimilar guidelines edge forward
18 February 2009
Japan's regulator, the PMDA , expects to finalise a new guideline for the regulation of follow-on biologics this year, following the first draft put out for public comment last September. This ...
New BTG propels itself for growth
20 January 2009
BTG , the UK's largest speciality pharmaceutical company, has bounced back from a recent dip in its share price, and has set its sights on becoming the next Shire . Earlier this month, BTG's stock ...
 
GSK's malaria vaccine sails towards uncharted territory
05 November 2009
GlaxoSmithKline will enter unknown regulatory waters when it eventually comes to seek approval of its paediatric malaria vaccine, RTS,S, the most advanced in development for this disease. The ...
Commentary - EC final report: bark worse than bite?
23 July 2009
On July 8th, 2009, the European Commission reported on its 18-month inquiry into competition in the pharmaceuticals sector. Bill Batchelor of Baker & McKenzie 's Brussels antitrust practice ...
Commentary: Japan's regulator has a plan, but needs to live up to it
04 June 2009
Scrip's Asia editor Ian Haydock casts a critical eye over a new international plan from Japan's regulator, the PMDA. Scrip's Tokyo-based Asia editor Ian Haydock Last month, Japan's drugs and ...
 
COMPANY/ORGANISATION
CONDITION
GEOGRAPHY
DRUG
© 2010 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36
Home
Therapy Sector
Generics
Business
Policy & Regulation
Research & Development
International
Terms & Conditions
Privacy Policy
Sitemap
About Us
Advertise
Subscribe
Scrip
Clinica
RAJ
Scrip Clinical Research
Animal Pharm